February 23, 2022
Market Analyst Marissa Wright Discusses the Psychedelics Market with a Focus on Alcohol Use Disorder
Learn More
February 3, 2022
Clearmind is proud to host Dr. Gabor Maté to discuss Alcoholism, Trauma, and Clearmind’s candidate treatments
Learn More
January 26, 2022
Clearmind’s Management Team Explained the Process Required by the FDA to Approve Clearmind’s MEAI as Medicine
Learn More
